Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth”

4,985 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 4,985 results

Early research (Phase 1)Study completedNCT03836859
What this trial is testing

Study to Evaluate Safety, Tolerability & PK of rhNGF in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Dompé Farmaceutici S.p.A 30
Not applicableStudy completedNCT04698759
What this trial is testing

Immune and Scfa Profile of Stunting Children

Who this might be right for
Immune DeficiencyStuntingFatty Acid
Bina Nusantara University 131
Large-scale testing (Phase 3)Active Not RecruitingNCT04305496
What this trial is testing

Capivasertib+Fulvestrant vs Placebo+Fulvestrant as Treatment for Locally Advanced (Inoperable) or Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 818
Testing effectiveness (Phase 2)Study completedNCT01441427
What this trial is testing

Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial

Who this might be right for
Feeding IntoleranceNecrotizing Enterocolitis
Ain Shams University 93
Not applicableStudy completedNCT02515266
What this trial is testing

Additional Protein Fortification in Extremely Low Birth Weight Infants

Who this might be right for
Premature BirthInfant, Extremely Low Birth WeightGrowth Failure
Hôpital de la Croix-Rousse 152
Not applicableLooking for participantsNCT05038462
What this trial is testing

Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction

Who this might be right for
Fetal Growth RetardationIntrauterine Growth Restriction
Institut d'Investigacions Biomèdiques August Pi i Sunyer 304
Not applicableUnknownNCT04909073
What this trial is testing

Observational Study of Afatinib 30 mg Daily

Who this might be right for
Non-Small Cell Lung CancerEpidermal Growth Factor Receptor Mutation
National University Hospital, Singapore 69
Not applicableStudy completedNCT00329069
What this trial is testing

The Role of Atorvastatin on Monocyte Function in Patients With Coronary Artery Disease and Hypercholesterolemia

Who this might be right for
Coronary Artery DiseaseHypercholesterolemiaMonocyte Function
University of Ulm 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07658183
What this trial is testing

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer (Locally Advanced or Metastatic)
Shanghai Best-Link Bioscience, LLC 120
Not applicableActive Not RecruitingNCT04640805
What this trial is testing

Targeted Fortification of Pasteurized Donor Human Milk

Who this might be right for
Very Low Birth Weight InfantGrowth FailureDonor Breast Milk
KK Women's and Children's Hospital 61
Early research (Phase 1)Study completedNCT01046266
What this trial is testing

Pharmacodynamics of RO5083945 in Patients With Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
Hoffmann-La Roche 62
Early research (Phase 1)Looking for participantsNCT04872166
What this trial is testing

BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Who this might be right for
Advanced Solid TumorMetastatic Breast Cancer
Edgewood Oncology Inc. 112
Testing effectiveness (Phase 2)WithdrawnNCT02355431
What this trial is testing

Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations

Who this might be right for
Solid Tumors and Hematologic MalignancyNSCLC (Non-small Cell Lung Carcinoma)
Incyte Corporation
Testing effectiveness (Phase 2)Active Not RecruitingNCT05383196
What this trial is testing

Onvansertib + Paclitaxel In TNBC

Who this might be right for
Breast CancerInvasive Breast CancerUnresectable Breast Carcinoma+7 more
Antonio Giordano, MD 50
Large-scale testing (Phase 3)Study completedNCT00362986
What this trial is testing

Topical Sunscreen in Preventing Skin Rash in Patients Receiving Drugs Such as Erlotinib or Cetuximab for Cancer

Who this might be right for
Dermatologic ComplicationsUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 116
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07393373
What this trial is testing

Open-Label, Long-Term, Extension Study of Infigratinib in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 135
Not applicableStudy completedNCT07062783
What this trial is testing

Effect of Aerobic Exercise on Biomarkers in Depression

Who this might be right for
Major Depression
Kutahya Health Sciences University 40
Early research (Phase 1)Study completedNCT00785941
What this trial is testing

IMC-A12 Every 2 Weeks in Patients With Tumors Who No Longer Respond to Treatment or No Treatment is Available

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 16
Not applicableUnknownNCT01609894
What this trial is testing

Individualized Fortification of Breast Milk

Who this might be right for
Postnatal Growth DisorderNeurodevelopment
McMaster Children's Hospital 112
Testing effectiveness (Phase 2)Ended earlyNCT04720729
What this trial is testing

Chemotherapy Monitoring by ctDNA in HER2- Metastatic Breast Cancer

Who this might be right for
HER2-negative Metastatic Breast Cancer
Institut Curie 160
Next Page